Test tubes are seen in front of a displayed Sputnik V logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

Indian biotech firm Panacea Biotec Ltd on Monday began production of Russia’s Sputnik V vaccine against Covid19, said the Russian Direct Investment Fund (RDIF), which markets the shot internationally.

The first batch made by the Indian manufacturer will be shipped to Gamaleya, the Moscow institute which developed the vaccine, for quality controls, RDIF said in a statement.

Full-scale production is expected to begin this summer, RDIF added. Panacea Biotec plans to produce 100 million doses of Sputnik V annually, RDIF said in April.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY